Ocera Therapeutics reports plans to price public offering of its stock

Stifel, Cowen are bookrunners; lead manager JMP Securities will assist

By Devika Patel

Knoxville, Tenn., July 9 – Ocera Therapeutics Inc. said it will price a public sale common stock.

Stifel and Cowen and Co. are the joint bookrunning managers and JMP Securities is the lead manager.

Proceeds will be used for clinical development of OCR-002, working capital and other general corporate purposes.

Ocera Therapeutics is a biopharmaceutical company based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.